News Of Emirates – Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, is partnering with Abu Dhabi Health Services Company – SEHA, the largest integrated healthcare network in the United Arab Emirates, to implement the Vocera Platform at the new Sheikh Shakhbout Medical City (SSMC). The 732-bed SSMC will be the first hospital within SEHA to standardize care team communication with Vocera solutions. There are future plans for SEHA to deploy the Vocera solution across 11 additional hospitals in the region.
Caregivers will use the wearable Vocera Smartbadge and the Vocera smartphone app to communicate hands-free via voice, send and receive secure messages, manage alerts and alarms, and more. The dynamic master directory of the Vocera Platform will enable clinicians to reach colleagues across the network simply by saying a name, role or group. There is no need to remember phone numbers or know who is on call.
“Standardizing clinical communication and collaboration on a single, secure platform will ensure we deliver seamless and consistent care across our medical center,” said Dr. Naser Mahmud Ammash, CEO, Sheikh Shakhbout Medical City.
The enterprise-grade communication platform will connect more than 1,800 caregivers and 440 physicians across SSMC. The largest hospital in the UAE, SSMC was established as part of the Abu Dhabi Economic Vision 2030 to elevate healthcare services in the Emirate. In 2019, SEHA partnered with Mayo Clinic to operate the 300,000-square-meter hospital, which provides specialist care for the most serious and complex conditions.
“Depending on the clinical situation, caregivers can use Vocera solutions to quickly connect and collaborate. Vocera solutions are purpose built to help hospitals and health system improve clinical efficiency, staff response times, quality of care, and patient safety,” said Gerald Francis, CNO, Sheikh Shakhbout Medical City.
Vocera solutions integrate with more than 150 clinical and operational systems, including electronic health records (EHR), nurse call systems, physiologic monitors, ventilators and more. Intelligent workflow integrations enable the delivery of relevant and contextual patient information to care team members at the right time on their device of choice, helping them make informed decisions quickly.
“Sheikh Shakhbout Medical City is the future of healthcare in the Emirate of Abu Dhabi, and effective care team communication is critical for its success,” said Rashed Al Rumaithi, CIO, Sheikh Shakhbout Medical City. “The intelligent Vocera Platform supports our vision to provide efficient, world-class care.”
Aiming to treat nearly 3,000 patients per day, the new SSMC is comprised of four interconnected towers dedicated to distinct specialties, including cardiology, orthopedics, maternity, general and pediatric surgery, critical care and more. The state-of the-art hospital is distinctive for providing advanced burn treatment and is considered a major medical facility specializing in intensive care services with 154 dedicated ICU beds.
“Sheikh Shakhbout Medical City is an impressive facility that will help lead new benchmarks in specialized services and critical care,” said Brent Lang, President and CEO of Vocera. “We are proud to provide an advanced communication platform that helps SEHA deliver exceptional care across its many healing environments, which successfully combine high-tech innovations with high-touch services.”
Abu Dhabi Health Services Company –SEHA is an independent, public joint stock company created to develop the curative activities of the public health care system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi. SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class health care. SEHA operates 12 hospitals with 2,644 beds, more than 60 ambulatory care, family care and urgent care centers and two blood banks. Its facilities accommodate 100,000 inpatients annually and conduct 41,000 surgeries, as well as treating more than 5 million outpatients. SEHA is one of the largest integrated health care providers in the Middle East, with more than 18,000 doctors, nurses, ancillary care and administrative personnel. Learn more about SEHA.
The mission of Vocera Communications, Inc. is to simplify and improve the lives of healthcare professionals and patients, while enabling hospitals to enhance quality of care and operational efficiency. In 2000, when the company was founded, we began to forever change the way care teams communicate. Today, Vocera offers the leading platform for improving clinical communication and workflow. More than 1,850 facilities worldwide, including nearly 1,600 hospitals and healthcare facilities, have selected our clinical communication and workflow solutions. Care team members use our solutions to communicate and collaborate with co-workers by securely texting or calling, and to be notified of important alerts and alarms. They can choose the right device for their role or task, including smartphones or our hands-free, wearable Vocera Smartbadge and Vocera Badge. Interoperability between the Vocera Platform and more than 150 clinical and operational systems helps reduce alarm fatigue; speed up staff response times; and improve patient care, safety, and experience. In addition to healthcare, Vocera is at home in luxury hotels, aged care facilities, retail stores, schools, power facilities, libraries, and more. Vocera solutions make mobile workers safer and more effective by enabling them to connect instantly with other people and access resources or information quickly. Vocera has made the list of Forbes 100 Most Trustworthy Companies in America. Learn more at www.vocera.com and follow @VoceraComm on Twitter.
GSMA Statement on Coronavirus
News Of Emirates – The GSMA is monitoring and assessing the potential impact of the Coronavirus on its MWC20 events held annually in Barcelona, Shanghai and Los Angeles and as well as the Mobile 360 Series of regional conferences. The upcoming MWC Barcelona event, 24-27 February 2020, will proceed as planned, across all venues at Fira Gran Via and Fira Montjuïc, including YoMo and Four Years From Now (4YFN). Specifically, for MWC Barcelona 2020, several measures are already in place, and updates can be found on www.mwcbarcelona.com/about/news/.
The GSMA will:
- Carefully follow and adhere to: the World Health Organisation’s (WHO) recommendations, all applicable Chinese government recommendations, all Spanish health authority recommendations and all police/health recommendations and protocols
- Provide additional medical personnel for on-site support in the run-up to and during the event
- Work with Fira de Barcelona to ensure sufficient sanitising products throughout all venues and implement other activity in line with recommendations from our city partners
- Support exhibitors who may not be able to travel to MWC Barcelona (via GSMA account managers or the Customer Care Team).
The GSMA confirms that there have been no registration impacts on MWC Barcelona thus far and further updates will be issued as advice develops. However, we strongly urge exhibitors and attendees to implement appropriate guidelines and protocols as suggested by the WHO and other health authorities to contain and mitigate against any further spread of the virus. Currently, the WHO has decided not to declare a global public health emergency, saying it was still too early for such a move and has advised that, ‘measures to limit the risk of exportation or importation of the disease should be implemented, without unnecessary restrictions of international traffic’. Up-to-date WHO advice can be found here: www.who.int/ith/2020-27-01-outbreak-of-Pneumonia-caused-by-new-coronavirus/en/ and the most recent press release issued by WHO is here:https://www.who.int/news-room/detail/28-01-2020-who-china-leaders-discuss-next-steps-in-battle-against-coronavirus-outbreak.
Merz Aesthetics Presents Data at the IMCAS World Congress 2020
News Of Emirates – Merz, a global leader in medical aesthetics, announced today that data on the Merz Aesthetics product portfolio, including Belotero®, Cellfina® and Radiesse® will be featured in oral and poster presentations at the 2020 International Master Course on Aging Science (IMCAS) World Congress, to be held from 30 January to 1 February 2020 in Paris, France.
“This meeting provides a platform for Merz Aesthetics to not only foster education and continuous training but also, to engage in thoughtful industry conversations while connecting with medical aesthetics physicians and fellow industry leaders from around the world,” said Bob Rhatigan, CEO of Merz Aesthetics. “We are grateful that our heritage and innovation in this space allows us to partner with world-renowned medical aesthetic experts, to share research on the diversified Merz Aesthetics product portfolio at the IMCAS World Congress.”
In addition to the poster presentations listed below, Merz Aesthetics is sponsoring the symposium event “Facial Rejuvenation: Interactive Sessions to Level-Up Your Injection Skills”, to be held on Saturday, 1 February at 10.30h – 12.30h, Room Amphi Bleu. The session will be opened by Bob Rhatigan, CEO of Merz Aesthetics and will include treatment insights from four international expert speakers:
- Dr. Tatjana Pavicic – Dermatologist, Germany
- Dr. Kate Goldie – Aesthetic Physician, United Kingdom
- Prof. Yana Yutskovskaya – Dermatologist, Russia
- Dr. Jani van Loghem – Aesthetic Physician, Netherlands
Independent presentations including data on the Merz Aesthetics portfolio:
What’s new in minimally invasive treatments
- Update on dermal fillers (99921) – Kate Goldie, MBChB – UK. Thursday, 30 January, 17.54 – 18.06h, Amphi Bleu – Level 2
Body shaping and cellulite
- Cellulite and skin laxity (93276). Doris Hexsel, Dermatologist – Brazil. Thursday, 30 January, 10.30 – 10.42h, Amphi Bleu – Level 2
- Cellulite treatment update: how dimples, laxity and volume can be effectively treated (98147)1. Gabriela Casabona, MD– Spain. Thursday, 30 January, 11.18 – 11.30h, Amphi Bleu – Level 2
- Biostimulators: how dilution/diffusion interferes with outcome (93391). Gabriela Casabona, MD – Spain. Saturday, 1 February, 16.30 – 16.42, Room 143 – Level 1
E-Posters will be available for viewing at the Poster Zone on Level 2, from Thursday, 30 January to Saturday, 1 February 2020.
- Distribution of cohesive polydensified matrix cross-linked hyaluronic acid volumizing gel in ex vivo human skin model. Christina Wollenburg, Jeanette Simon, Dr. Kay Marquardt, Dr. Thomas Hengl – all Merz Pharmaceuticals GmbH, Germany.
- Calcium hydroxylapatite microspheres provide organization into unorganized collagen networks leading to improvement of skin attractiveness. Gabriela Casabona, MD – Spain. Dr. Bartosch Nowag, Daniela Schäfer, Davide Greco, Dr. Thomas Hengl – all Merz Pharmaceuticals GmbH, Germany.
This year, Merz is also celebrating the ten-year anniversary of BOCOUTURE® (incobotulinumtoxin A) in Europe. The botulinum toxin is part of the Merz Aesthetics portfolio and has received approval in 15 countries in Europe within the last ten years. A Booth Talk about “BOCOUTURE® – 10 Years of a Unique Neurotoxin” with Dr. Thomas Rappl will take place Friday, 31 January, 16.00, Booth N° P251.
Copyright © 2019 Merz Pharma GmbH & Co. KGaA. All rights reserved. MERZ, MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz Pharma GmbH & Co. KgaA.
Merz is a global, diversified healthcare company based in Frankfurt, Germany. Privately-held for more than 111 years, the company operates in the areas of aesthetics, therapeutics and consumer care and is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In fiscal year 2018/19, Merz generated revenue of EUR 1,094 million; the company has a total workforce of 3,213 employees worldwide and a direct presence in 28 countries.
Kioxia Appoints Nobuo Hayasaka as President and CEO
News Of Emirates – Kioxia Holdings Corporation today announced that the Board of Directors has appointed Nobuo Hayasaka as President and CEO of Kioxia, effective immediately. Dr. Hayasaka has served as Acting President and CEO since July 12, 2019, during Former President and CEO Yasuo Naruke’s medical leave of absence.
Dr. Naruke notified the company’s Board of Directors of his desire to step down as President, CEO and member of the board as he continues to focus on his health.
“Dr. Naruke has been an outstanding leader for our company over many years, and we thank him for the invaluable contribution he has made to shaping us into the company we are today.” said Stacy J. Smith, Executive Chairman of Kioxia. “This year presents an exciting opportunity for Kioxia, and President Hayasaka has the skills, experience and the full backing of our Board of Directors, management and employees as we move toward a new era of memory. I look forward to working closely with President Hayasaka and the rest of the executive team to ensure Kioxia’s ongoing success and value creation.”
“I am honored to be given the opportunity to serve as President and CEO of Kioxia. I am aware of the tremendous responsibility and look forward to continuing to work closely with our senior leadership team and employees to grow the company,” said Nobuo Hayasaka. “In order to maintain our position as a market leader in the new era of memory, we will continue to develop our core memory technology, while also investing in new ideas and innovations. We are committed to creating “value” through “memory,” which is what our company name implies, and developing new ways to contribute to the betterment of society.”
Dr. Hayasaka first joined Toshiba Corporation in 1984 after receiving a Ph.D in Electronic Engineering from Tohoku University. He was promoted to the position of Chief Technology Executive of Semiconductor and Storage Company in 2013 and held the role of Executive Officer, Corporate Vice President in 2014. Following Toshiba Memory’s separation from Toshiba Corporation, he was appointed as Executive Vice President, Executive Officer and Chief Technology Officer. He was appointed Acting President and CEO in July 2019.
Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with memory by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia’s innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, SSDs, automotive and data centers.
World5 months ago
Fujairah oil product stocks decline by 2.7 percent
Business4 months ago
GSMA Statement on Coronavirus
Entertainment5 months ago
The Laughter Factory’s ‘Start 2020 Completely Wrong! tour’
Emirates2 months ago
National Ambulance releases video to promote ‘Stay Home’ campaign
Health4 months ago
Rare Disease CDKL5 Deficiency Disorder Granted WHO Disease Classification
Business5 months ago
Esri Joins HERE Technologies at CES 2020
Emirates2 months ago
Dubai Municipality closes all external customer service centres
Business5 months ago
Analogix Introduces Industry’s Lowest Power UHD eDP TCON With 3D Color Gamut Rotation and In-Cell Touch